As the price of sequencing an individual’s genome becomes as cheap as $1000, scientists and bioethicists discuss the risks and benefits of large populations of the public having their genome sequenced. Their concern addresses questions of accuracy and the risk of false positives as well as the potential of genetic discrimination for things like life and disability insurance. NPR covers the story here.
